Thapsigargin analogues (GenSpera)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameThapsigargin analogues (GenSpera)
Drug Alias NameAc-GKAFRR-L12ADTG-301G-301(GenSpera)
ClassificationSmall molecules > Heterocyclic drugsSmall molecules > Synthetic peptideSmall molecules > Prodrug
Mechanisms of ActionSarcoplasmic reticulum calcium-transporting ATPases inhibitorsKallikrein 2 inhibitors
TargetsSarcoplasmic reticulum calcium-transporting ATPasesKallikrein 2
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGenspera Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJohns Hopkins University Sidney Kimmel Comprehensive Cancer CenterGenspera IncDanish University Of Pharmaceutical Sciences
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A